Skip to main content

Table 5 Correlation between hsa-miR-182-5p (miR-182) and target genes in patients with ovarian cancer(n = 376)

From: Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis

miRNA

Target gene

r

p-value

FDR

hsa-miR-182-5p

TPM1

−0.143

5.61E-03

1.99E-02

hsa-miR-182-5p

COL1A1

−0.154

2.74E-03

1.14E-02

hsa-miR-182-5p

PDGFRA

−0.18

4.40E-04

2.87E-03

hsa-miR-182-5p

UBE2B

−0.149

3.87E-03

1.49E-02

hsa-miR-182-5p

MEF2C

−0.201

8.70E-05

8.01E-04

hsa-miR-182-5p

SNAI2

−0.154

2.84E-03

1.18E-02

hsa-miR-182-5p

CACNA2D1

−0.104

4.44E-02

1.01E-01

hsa-miR-182-5p

RECK

−0.153

2.93E-03

1.21E-02

hsa-miR-182-5p

FOXO1

−0.115

2.57E-02

6.58E-02

hsa-miR-182-5p

FBN1

−0.139

6.81E-03

2.33E-02

hsa-miR-182-5p

ANTXR2

−0.187

2.62E-04

1.90E-03

hsa-miR-182-5p

NKX3–1

−0.136

8.32E-03

2.70E-02

hsa-miR-182-5p

TIMP2

−0.194

1.51E-04

1.23E-03

hsa-miR-182-5p

AKT3

−0.205

6.28E-05

6.32E-04

hsa-miR-182-5p

RBPMS

−0.17

9.57E-04

5.21E-03

hsa-miR-182-5p

EGLN3

−0.113

2.83E-02

7.09E-02

hsa-miR-182-5p

DERL1

−0.164

1.41E-03

6.98E-03

hsa-miR-182-5p

PRKD1

−0.177

5.57E-04

3.44E-03

hsa-miR-182-5p

SLC2A13

−0.115

2.57E-02

6.58E-02

hsa-miR-182-5p

MAF

−0.268

1.26E-07

5.19E-06

hsa-miR-182-5p

DCN

−0.236

3.68E-06

6.45E-05

  1. miRNA or miR, microRNA, FDR false discovery rate